Lan Yao, Zhang Xiaohuan, Liu Zhongmei, Zhou Li, Shen Ruihua, Zhong Xianping, Cui Wenjing, Zhou Zhemin
Key Laboratory of Industrial Biotechnology (Ministry of Education), School of Biotechnology, Jiangnan University, Wuxi, China.
ENNova Health Science Technology Co., Ltd., ENN Group, Langfang, Hebei, China.
PLoS One. 2017 Jun 23;12(6):e0179833. doi: 10.1371/journal.pone.0179833. eCollection 2017.
Nitrile hydratase (NHase) from Rhodococcus rhodochrous J1 is widely used for industrial production of acrylamide and nicotinamide. However, the two types of NHases (L-NHase and H-NHase) from R. rhodochrous J1 were only slightly expressed in E. coli by routine methods, which limits the comprehensive and systematic characterization of the enzyme properties. We successfully expressed the two types of recombinant NHases in E. coli by codon-optimization, engineering of Ribosome Binding Site (RBS) and spacer sequences. The specific activity of the purified L-NHase and H-NHase were 400 U/mg and 234 U/mg, respectively. The molecular mass of L-NHase and H-NHase was identified to be 94 kDa and 504 kDa, respectively, indicating that the quaternary structure of the two types of NHases was the same as those in R. rhodochrous J1. H-NHase exhibited higher substrate and product tolerance than L-NHase. Moreover, higher activity and shorter culture time were achieved in recombinant E. coli, and the whole cell catalyst of recombinant E. coli harboring H-NHase has equivalent efficiency in tolerance to the high-concentration product relative to that in R. rhodochrous J1. These results indicate that biotransformation of nitrile by R. rhodochrous J1 represents a potential alternative to NHase-producing E. coli.
来自红平红球菌J1的腈水合酶(NHase)被广泛用于丙烯酰胺和烟酰胺的工业生产。然而,通过常规方法,红平红球菌J1的两种类型的NHase(L-NHase和H-NHase)在大肠杆菌中表达量很低,这限制了对该酶特性的全面系统表征。我们通过密码子优化、核糖体结合位点(RBS)工程和间隔序列,成功在大肠杆菌中表达了这两种类型的重组NHase。纯化后的L-NHase和H-NHase的比活性分别为400 U/mg和234 U/mg。L-NHase和H-NHase的分子量分别被鉴定为94 kDa和504 kDa,表明这两种类型的NHase的四级结构与红平红球菌J1中的相同。H-NHase比L-NHase表现出更高的底物和产物耐受性。此外,重组大肠杆菌实现了更高的活性和更短的培养时间,并且携带H-NHase的重组大肠杆菌全细胞催化剂在对高浓度产物的耐受性方面与红平红球菌J1相当。这些结果表明,红平红球菌J1对腈的生物转化是生产NHase的大肠杆菌的一种潜在替代方法。